| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
292.83(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
80,031 |
461,916 |
540,416 |
831,596 |
| Total Sell Value |
$14,256,265 |
$81,646,316 |
$93,320,391 |
$138,453,569 |
| Total People Sold |
2 |
9 |
9 |
12 |
| Total Sell Transactions |
2 |
11 |
13 |
29 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Richmond Timothy J. |
EVP, Chief HR Officer |
• – – |
2020-11-27 |
4 |
S |
$105.00 |
$5,458,950 |
D/D |
(51,990) |
0 |
|
-3% |
|
| Richmond Timothy J. |
EVP, Chief HR Officer |
• – – |
2020-11-27 |
4 |
OE |
$51.42 |
$2,673,326 |
D/D |
51,990 |
51,990 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2020-11-20 |
4 |
S |
$98.83 |
$3,975,046 |
D/D |
(40,000) |
20,006 |
|
-5% |
|
| Alban Carlos |
Vice Chairman |
• – – |
2020-11-16 |
4 |
S |
$100.00 |
$11,583,000 |
D/D |
(115,830) |
114,899 |
|
-9% |
|
| Alban Carlos |
Vice Chairman |
• – – |
2020-11-16 |
4 |
OE |
$35.88 |
$4,155,980 |
D/D |
115,830 |
230,729 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2020-11-12 |
4 |
S |
$97.06 |
$18,851,790 |
D/D |
(194,154) |
318,642 |
|
-6% |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2020-11-12 |
4 |
OE |
$54.86 |
$11,089,858 |
D/D |
194,154 |
512,796 |
|
- |
|
| Saleki-Gerhardt Azita |
EVP, Operations |
• – – |
2020-11-10 |
4 |
S |
$98.00 |
$1,707,748 |
D/D |
(17,426) |
96,441 |
|
-6% |
|
| Sorg Elaine K. |
Sr. V.P., U.S. Commercial Ops. |
• – – |
2020-11-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,595 |
|
11% |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2020-11-09 |
4 |
S |
$95.74 |
$3,585,463 |
D/D |
(37,450) |
318,642 |
|
-11% |
|
| Saleki-Gerhardt Azita |
EVP, Operations |
• – – |
2020-11-04 |
4/A |
S |
$93.61 |
$449,328 |
D/D |
(4,800) |
113,867 |
|
- |
|
| Saleki-Gerhardt Azita |
EVP, Operations |
• – – |
2020-11-04 |
4/A |
OE |
$24.21 |
$116,199 |
D/D |
4,800 |
118,667 |
|
- |
|
| Saleki-Gerhardt Azita |
EVP, Operations |
• – – |
2020-11-04 |
4 |
AS |
$93.61 |
$449,328 |
D/D |
(4,800) |
109,067 |
|
11% |
|
| Severino Michael |
Vice Chairman |
• – – |
2020-11-04 |
4 |
S |
$93.61 |
$8,488,461 |
D/D |
(90,679) |
67,281 |
|
-11% |
|
| Rapp Edward J |
Director |
– • – |
2020-09-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,513 |
10,388 |
|
- |
|
| Rapp Edward J |
Director |
– • – |
2020-09-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,513 |
25,482 |
|
- |
|
| Alban Carlos |
Vice Chairman |
• – – |
2020-07-07 |
4 |
S |
$100.00 |
$5,332,555 |
D/D |
(53,325) |
114,899 |
|
1% |
|
| Stewart Jeffrey Ryan |
SVP, US Commercial Operations |
• – – |
2020-05-12 |
4 |
S |
$90.00 |
$2,072,211 |
D/D |
(23,024) |
52,760 |
|
-1% |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
23,196 |
63,538 |
|
- |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
7,882 |
|
- |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,000 |
|
7% |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
114,759 |
|
7% |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
4,000 |
|
- |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
114,759 |
|
- |
|
| Austin Roxanne S |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
119,447 |
|
- |
|
765 Records found
|
|
Page 12 of 31 |
|
|
3.30 (2.04%) 
